EFFECT OF MURINE RECOMBINANT IL-2 ON THE COURSE OF LUPUS-LIKE DISEASE IN (NZB×NZW) F₁ Female Mice

REFERENCES

• Vial T., Chevrel G., Descotes J. Drugs Acting on the Immune System. Meyler's Side-Effects of Drugs, M.N.G. Dukes, J.K. Aronson. 14, Elsevier Sciences, Amsterdam 2000; 1246–1337
   Google Scholar
• Dumoulin F.L., Leifeld L., Sauerbruch T., Spengler U. Autoimmunity Induced by Interferon-alpha Therapy for Chronic Viral Hepatitis. Biomed. Pharmacother. 1999; 53(5–6)242–254
   PubMedGoogle Scholar
• Schlegel P.J., Samlowski W.E., Ward J.H. Autoimmune Hemolytic Anemia in a Patient with Chronic Lymphocytic Leukemia and Renal Cell Carcinoma After Treatment with High-dose Intravenous Bolus Interleukin-2. J. Immunother. 2000; 23(4)507–508
   PubMedGoogle Scholar
• Miossec P. Cytokine-induced Auto-immune Disorders. Drug Saf. 1997; 17(2)93–104
   PubMedGoogle Scholar
• Gutierrez-Ramos J.C., Moreno de Alboran I., Martinez C. In Vivo Administration of Interleukin-2 Turns on Anergic Self-reactive T Cells and Leads to Autoimmune Disease. Eur. J. Immunol. 1992; 22(11)2867–2872
   PubMedGoogle Scholar
• Andrew-Sanchez J.L., Moreno de Alboran I.M., Marcos M.A., Sanchez-Movilla A., Martinez A.C., Kroemer G. Interleukin 2 Abrogates the Nonresponsive State of T Cells Expressing a Forbidden T Cell Receptor Repertoire and Induces Autoimmune Disease in Neonatally Thymectomized Mice. J. Exp. Med. 1991; 173(6)1323–1329
   PubMedGoogle Scholar
• Kroemer G., Francese C., Martinez C. The Role of Interleukin 2 in the Development of Autoimmune Thyroiditis. Int. Rev. Immunol. 1992; 9(2)107–123
   PubMedGoogle Scholar
• Serreze D.V., Hamaguchi K., Leiter E.H. Immunostimulation Circumvents Diabetes in NOD/Lt mice. J. Autoimmun. 1989; 2(6)759–776
   PubMedGoogle Scholar
• Owen K.L., Shibata T., Izui S., Walker S.E. Recombinant Interleukin-2 Therapy of Systemic Lupus Erythematosus in the New Zealand Black/New Zealand White Mouse. J. Biol. Response Mod. 1989; 8(4)366–374
   PubMedGoogle Scholar
• Kashima N., Nishi-Takaoka C., Fujita T., Taki S., Yamada G., Hamuro J., Taniguchi T. Unique Structure of Murine Interleukin-2 as Deduced from Cloned cDNAs. Nature 1985; 313(6001)402–4044
   PubMedGoogle Scholar
• Putterman C., Naparstek Y. Murine Models of Spontaneous Systemic Lupus Erythematosus. Autoimmune Disease Models. 1, Academic Press, Inc., London 1994; 217–241
   Google Scholar
• Brocher A., Ansari A.A., Hsu T., Kono D.H., Gershwin M.E. The Pathogenesis of Autoimmunity in New Zealand Mice. Semin Arthritis Rheum. 2000; 29(6)385–399
   PubMedGoogle Scholar
• Howie J.B., Helyer B.J. The Immunology and Pathology of NZB Mice. Adv. Immunol. 1968; 9: 215–266
   PubMedGoogle Scholar
• Theofilopoulos A.N., Dixon F.J. Murine Models of Systemic Lupus Erythematosus. Adv. Immunol. 1985; 37: 269–390
   PubMed Web of Science ®Google Scholar
• Prummer O. Treatment-induced Antibodies to Interleukin-2. Biotherapy 1997; 10(1)15–24
   PubMedGoogle Scholar
• Banerjee S., Wei B.Y., Hillman K., Luthra H.S., David C.S. Immunosuppression of Collagen-induced Arthritis in Mice with an Anti-IL-2 Receptor Antibodie. J. Immunol. 1988; 141: 1150–1154
   PubMed Web of Science ®Google Scholar
• Kelley V.E., Gaulton G.N., Hattori M., Ikegami H., Eisenbarth G., Strom T.B. Anti-interleukin-2 Receptor Antibody Suppresses Murine Diabetic Insulitis and Lupus Nephritis. J. Immunol. 1988; 140: 59–61
   PubMedGoogle Scholar
• Rizzo L.V., Miller-Rivero N.E., Chan C.C., Wiggert B., Nussenblatt R.B., Caspi R.R. Interleukin-2 Treatment Potentiates Induction of Oral Tolerance in a Murine Model of Autoimmunity. J. Clin. Invest. 1994; 4(4)1668–1672
   Google Scholar
• Huggins M.L., Huang F.P., Xu D., Lindop G., Stott D.I. Modulation of Autoimmune Disease in the MRL-lpr/lpr Mouse by IL-2 and TGF-beta1 Gene Therapy using Attenuated Salmonella Typhimurium as Gene Carrier. Lupus 1999; 8(1)29–38
   PubMedGoogle Scholar
• Pollard K.M., Pearson D.L., Hultman P., Hildebrandt B., Kono D.H. Lupus-prone Mice as Models to Study Xenobiotic-induced Acceleration of Systemic Autoimmunity. Environ. Health Perspect 1999; 107(Suppl 5)729–735
   PubMedGoogle Scholar
• Heyler B., Howie J. Renal Disease Associated with Positive Lupus Erythematosus Tests in a Crossbred Strain of Mice. Nature 1963; 197: 197
   Google Scholar
• Walker S.E. Accelerated Mortality in Young NZB/NZW Mice Treated with the Interferon Inducer Tilorone Hydrochloride. Clin. Immunol. Immunopathol. 1977; 8(2)204–212
   PubMedGoogle Scholar
• White K.L. Silicone Gel and Animal Models of Autoimmune Disease. Clin. Immunol. Immunopathol. 1998; 87(3)205–206
   PubMedGoogle Scholar
• McDonald A.H., Weir K., Schneider M., Gudenkauf L., Sanger J.R. Silicone Gel Enhances the Development of Autoimmune Disease in New Zealand Black Mice but Fails to Induce it in BALB/cAnPt Mice. Clin. Immunol. Immunopathol. 1998; 87(3)248–255
   PubMedGoogle Scholar
• Mosmann T.R., Yokota T., Kastelein R., Zurawski S.M., Arai N., Takebe Y. Species-specificity of T Cell Stimulating Activities of IL-2 and BSF-1 (IL-4): Comparison of Normal and Recombinant, Mouse and Human IL-2 and BSF-1 (IL-4). J. Immunol. 1987; 138(6)1813–1816
   PubMed Web of Science ®Google Scholar
• Huang F.P., Stott D.I. Restoration of an Early, Progressive Defect in Responsiveness to T-cell Activation in Lupus Mice by Exogenous IL-2. Autoimmunity 1993; 15(1)19–29
   PubMed Web of Science ®Google Scholar
• Lentsch A.B., Nakagawa K., Yoshidome H., Gerassimides A., Miller F.N., Edwards M.J. Distinct Biological Activities of Recombinant Forms of Human Interleukin-2 In vivo. Cancer Immunol. Immunother 1997; 43(6)331–336
   PubMedGoogle Scholar
• Thornton S., Boivin G.P., Kim K.N., Finkelman F.D., Hirsch R. Heterogeneous Effects of IL-2 on Collagen-induced Arthritis. J. Immunol. 2000; 165(3)1557–1563
   PubMedGoogle Scholar
• Singh V.K., Mehrotra S., Agarwal S.S. The Paradigm of Th1 and Th2 Cytokines: its Relevance to Autoimmunity and Allergy. Immunol. Res. 1999; 20(2)147–161
   PubMed Web of Science ®Google Scholar
• Luster M.I., Simeonova P.P, Gallucci R., Matheson J. Autoimmunity and Risk Assessment. Environ. Health Perspect. 1999; 107(suppl 5)679–680
   PubMedGoogle Scholar
• Kono D.H., Theophilopoulos A.N. Genetics of Autoimmunity in Mouse Models of Lupus. Int. Rev. Immunol. 2000; 19(4–5)367–387
   PubMedGoogle Scholar